BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Kelun-Biotech's Phase III Trial of SKB264 Meets Endpoint in Advanced TNBC

Kelun-Biotech recently held an Independent Data Monitoring Committee (IDMC) meeting to review the interim analysis data of the Phase III clinical trial of ...

August 15, 2023 | News

Leading Asia Pacific Biopharmas Power Digital Engagement with Veeva CRM

Veeva Systems announced that 18 of the top 20 biopharmas in Asia Pacific are using Veeva CRM for more effective engagement ...

August 15, 2023 | News

Surging demand for Korean pharma in 2023 ahead of CPHI Korea

In exciting news for the Korean pharma, the industry in Korea has seen its ‘growth potential’ increase by 7% in the 2023 CPHI Annual Survey[1]....

August 11, 2023 | News

GenScript Biotech and T-MAXIMUM Biotech Form Strategic Alliance on cGMP sgRNA

GenScript Biotech, the world's leading life-science research tools and services provider, and T-MAXIMUM Biotech, a biotechnology company pioneering u...

August 10, 2023 | News

Lonza Launches Nebula® Absorbance Reader for Streamlined Endotoxin and Pyrogen Testing

Lonza adds new Nebula® Absorbance Reader to its portfolio of Lonza-developed and optimized microplate readers for streamlined endotoxin and pyrogen t...

August 09, 2023 | News

Next-Level Biologics Manufacturing: Lonza Launches TheraPRO® CHO Media System to Drive Protein Production Efficiency

Lonza has recently launched a new cell culture platform — the TheraPRO® CHO Media System. Can you tell us more about it? What are the key...

August 07, 2023 | Influencers

Waters Launches XBridge Premier GTx BEH SEC Columns for Gene Therapy Applications

Reduces the cost of gene therapies by using 3-10x less sample than other methodsi while generating faster results and more drug substance informatio...

August 03, 2023 | News

China's Mabwell Announces NMPA Approval of Novel B7-H3 ADC (7MW3711) for IND

B7-H3 is a member of the B7 ligand family and is overexpressed in most cancer types but expressed at a low level in normal tissues. In malignant tissues, B...

July 24, 2023 | News

Mabwell Announces the NMPA Approval of Novel Trop-2 ADC (9MW2921) for IND

9MW2921 is a next generation antibody-drug conjugate (ADC) developed by Mabwell based on IDDC™ (Interchain-Disulfide Drug Conjugate) platef...

July 19, 2023 | News

Duoning Biotech Acquires PreFluid to Strengthen Fluid Management Solutions

PreFluid is a leader in integrated fluid solutionsPreFluid's peristaltic pumps are widely used in medical, pharmaceutical, chemical and environmental indus...

July 19, 2023 | News

Antengene Administers First Patient in US Clinical Study of ATG-017 for Advanced Solid Tumors with Nivolumab Combination

- ATG-017 is an oral, potent and selective small molecule ERK1/2 inhibitor. Antengene has exclusive global rights to develop...

July 18, 2023 | News

SK Biopharmaceuticals Makes Big Bets to be 'Big Biotech'

SK Biopharmaceuticals CEO Donghoon Lee maps out its medium to long-term strategy at a press conference SK Biopharmaceuticals mobilizes its cutti...

July 18, 2023 | News

Lonza Launches TheraPRO® CHO Media System

Lonza’s new cell culture media system is designed to optimize the production of therapeutic monoclonal antibodies The two-part production system i...

July 17, 2023 | News

Harbour BioMed's 2023 Interim Results: Positive Profit Alert Driven by Innovation

Based on the preliminary review of the Company's unaudited management accounts for the six months ended June 30, 2023, the total revenue is ex...

July 14, 2023 | News

Stay Connected